Good morning :)
Place Order
Add to Watchlist

Mangalam Drugs and Organics Ltd

MANGALAM Share Price

81.280.71% (+0.57)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹128 cr, stock is ranked 2,856

Stock is 3.31x as volatile as Nifty

MANGALAM Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹128 cr, stock is ranked 2,856

Stock is 3.31x as volatile as Nifty

MANGALAM Performance & Key Metrics

MANGALAM Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
19.120.95
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.486.570.80%

MANGALAM Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

MANGALAM Company Profile

Mangalam Drugs and Organics Limited is engaged in the manufacturing of drugs, medicines and allied products. The Company also manufactures active pharma ingredients (API), intermediates and specialty chemicals.

MANGALAM Similar Stocks (Peers)

Compare with peers Compare with peers 

MANGALAM Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
36.60
36.60
1Y Return
9.68%
9.68%
Buy Reco %
87.88
87.88
PE Ratio
23.22
23.22
1Y Return
2.47%
2.47%
Buy Reco %
74.19
74.19
PE Ratio
60.51
60.51
1Y Return
22.85%
22.85%
Buy Reco %
75.00
75.00
PE Ratio
18.79
18.79
1Y Return
0.48%
0.48%
Buy Reco %
55.17
55.17
PE Ratio
22.29
22.29
1Y Return
7.25%
7.25%
Buy Reco %
46.43
46.43
Compare with Peers

MANGALAM Forecast

MANGALAM Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

MANGALAM

MANGALAM

Income

Balance Sheet

Cash Flow

MANGALAM Income Statement

MANGALAM Income Statement

Loading...

Financial YearFY 2024FY 2025TTM
Total Revenue368.69318.73318.74
Raw Materialssubtract235.41282.41282.41
Power & Fuel Costsubtract28.50
Employee Costsubtract39.07
Selling & Administrative Expensessubtract13.08
Operating & Other expensessubtract35.14
Depreciation/Amortizationsubtract14.6516.6116.60
Interest & Other Itemssubtract13.9214.9314.94
Taxes & Other Itemssubtract-2.00-1.94-1.94
EPS-5.744.254.25
DPS0.000.000.00
Payout ratio0.000.000.00

MANGALAM Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF

Investor Presentation

Aug 3PDF
FY 2016FY 2016

Annual report

PDF

Investor Presentation

May 24PDF
FY 2015FY 2015

Annual report

PDF
 

MANGALAM Stock Peers

MANGALAM Past Performance & Peer Comparison

MANGALAM Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Mangalam Drugs and Organics Ltd19.140.95
Sun Pharmaceutical Industries Ltd36.605.960.96%
Cipla Ltd23.223.911.06%
Torrent Pharmaceuticals Ltd60.5116.870.94%

MANGALAM Stock Price Comparison

Compare MANGALAM with any stock or ETF
Compare MANGALAM with any stock or ETF
MANGALAM
Loading...

MANGALAM Holdings

MANGALAM Shareholdings

MANGALAM Promoter Holdings Trend

MANGALAM Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

MANGALAM Institutional Holdings Trend

MANGALAM Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

MANGALAM Shareholding Pattern

MANGALAM Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding50.30%0.00%0.00%0.47%49.23%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

MANGALAM Shareholding History

MANGALAM Shareholding History

Dec '23MarJunSepDec '24Mar0.10%0.26%0.21%0.11%0.11%0.47%

MANGALAM Insider Trades & Bulk Stock Deals

MANGALAM Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing MANGALAM stock

smallcases containing MANGALAM stock

Looks like this stock is not in any smallcase yet.

MANGALAM Events

MANGALAM Events

MANGALAM Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

MANGALAM has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

MANGALAM Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

MANGALAM has not given any dividends in last 5 years

MANGALAM Upcoming Dividends

MANGALAM Upcoming Dividends

No upcoming dividends are available

MANGALAM Past Dividends

MANGALAM Past Dividends

Cash Dividend

Ex DateEx DateDec 21, 2017

Interim
Interim | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Dec 21, 2017

MANGALAM Stock News & Opinions

MANGALAM Stock News & Opinions

Earnings
Mangalam Drugs and Organics consolidated net profit declines 98.30% in the March 2025 quarter

Net profit of Mangalam Drugs and Organics declined 98.30% to Rs 0.06 crore in the quarter ended March 2025 as against Rs 3.53 crore during the previous quarter ended March 2024. Sales declined 28.61% to Rs 72.78 crore in the quarter ended March 2025 as against Rs 101.94 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 6.72 crore in the year ended March 2025 as against net loss of Rs 9.07 crore during the previous year ended March 2024. Sales declined 13.55% to Rs 317.58 crore in the year ended March 2025 as against Rs 367.35 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales72.78101.94 -29 317.58367.35 -14 OPM %13.9611.47 -11.284.73 - PBDT6.347.79 -19 21.393.58 497 PBT1.633.93 -59 4.79-11.07 LP NP0.063.53 -98 6.72-9.07 LP Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Mangalam Drugs and Organics announces board meeting date

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 17 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Mangalam Drugs and Organics to conduct board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 11 April 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Mangalam Drugs and Organics standalone net profit rises 180.00% in the December 2024 quarter

Net profit of Mangalam Drugs and Organics rose 180.00% to Rs 1.40 crore in the quarter ended December 2024 as against Rs 0.50 crore during the previous quarter ended December 2023. Sales declined 8.76% to Rs 88.55 crore in the quarter ended December 2024 as against Rs 97.05 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales88.5597.05 -9 OPM %9.907.18 - PBDT5.413.66 48 PBT1.480.04 3600 NP1.400.50 180 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Mangalam Drugs and Organics to convene board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Mangalam Drugs and Organics receives upgrade in credit ratings from CRISIL

Mangalam Drugs and Organics has received upgrade in credit ratings from CRISIL as under: Long term rating - CRISIL BBB-; Stable (upgraded from CRISIL BB+; Stable) Short term rating - CRISIL A3 (upgraded from CRISIL A4+)Powered by Capital Market - Live

5 months agoCapital Market - Live
Spotlight
Mangalam Drugs and Organics Ltd leads gainers in 'B' group

Soma Textiles & Industries Ltd, Saraswati Saree Depot Ltd, Pudumjee Paper Products Ltd and Balaji Telefilms Ltd are among the other gainers in the BSE's 'B' group today, 29 November 2024.Mangalam Drugs and Organics Ltd surged 16.99% to Rs 125.3 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.71 lakh shares were traded on the counter so far as against the average daily volumes of 2411 shares in the past one month. Soma Textiles & Industries Ltd spiked 16.18% to Rs 63.06. The stock was the second biggest gainer in 'B' group. On the BSE, 2.06 lakh shares were traded on the counter so far as against the average daily volumes of 27213 shares in the past one month. Saraswati Saree Depot Ltd soared 11.53% to Rs 141.75. The stock was the third biggest gainer in 'B' group. On the BSE, 73043 shares were traded on the counter so far as against the average daily volumes of 11982 shares in the past one month. Pudumjee Paper Products Ltd advanced 11.32% to Rs 157.4. The stock was the fourth biggest gainer in 'B' group. On the BSE, 3.15 lakh shares were traded on the counter so far as against the average daily volumes of 1.07 lakh shares in the past one month. Balaji Telefilms Ltd added 11.28% to Rs 71.3. The stock was the fifth biggest gainer in 'B' group. On the BSE, 1.72 lakh shares were traded on the counter so far as against the average daily volumes of 12588 shares in the past one month. Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Mangalam Drugs and Organics reports standalone net profit of Rs 2.69 crore in the September 2024 quarter

Net profit of Mangalam Drugs and Organics reported to Rs 2.69 crore in the quarter ended September 2024 as against net loss of Rs 3.56 crore during the previous quarter ended September 2023. Sales declined 1.99% to Rs 79.75 crore in the quarter ended September 2024 as against Rs 81.37 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales79.7581.37 -2 OPM %10.912.69 - PBDT5.17-1.02 LP PBT1.20-4.75 LP NP2.69-3.56 LP Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Mangalam Drugs and Organics to table results

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Mangalam Drugs and Organics AGM scheduled

Mangalam Drugs and Organics announced that the 51th Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Mangalam Drugs and Organics Ltd (MANGALAM) today?

    The share price of MANGALAM as on 1st July 2025 is ₹81.28. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Mangalam Drugs and Organics Ltd (MANGALAM) share?

    The past returns of Mangalam Drugs and Organics Ltd (MANGALAM) share are
    • Past 1 week: -0.39%
    • Past 1 month: 1.48%
    • Past 3 months: 3.29%
    • Past 6 months: -32.10%
    • Past 1 year: -22.09%
    • Past 3 years: -41.50%
    • Past 5 years: 10.21%

  3. What are the peers or stocks similar to Mangalam Drugs and Organics Ltd (MANGALAM)?
  4. What is the market cap of Mangalam Drugs and Organics Ltd (MANGALAM) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mangalam Drugs and Organics Ltd (MANGALAM) is ₹128.65 Cr as of 1st July 2025.

  5. What is the 52 week high and low of Mangalam Drugs and Organics Ltd (MANGALAM) share?

    The 52-week high of Mangalam Drugs and Organics Ltd (MANGALAM) is ₹144.99 and the 52-week low is ₹70.10.

  6. What is the PE and PB ratio of Mangalam Drugs and Organics Ltd (MANGALAM) stock?

    The P/E (price-to-earnings) ratio of Mangalam Drugs and Organics Ltd (MANGALAM) is 19.14. The P/B (price-to-book) ratio is 0.95.

  7. Which sector does Mangalam Drugs and Organics Ltd (MANGALAM) belong to?

    Mangalam Drugs and Organics Ltd (MANGALAM) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Mangalam Drugs and Organics Ltd (MANGALAM) shares?

    You can directly buy Mangalam Drugs and Organics Ltd (MANGALAM) shares on Tickertape. Simply sign up, connect your demat account and place your order.